Editorial

You have full text access to this OnlineOpen article

Is high-dose intensity intraarterial cisplatin chemoradiotherapy for head and neck carcinoma feasible?†

  1. K. Thomas Robbins M.D.‡,*

Article first published online: 4 JAN 2005

DOI: 10.1002/cncr.20807

Issue

Cancer

Cancer

Volume 103, Issue 3, pages 447–450, 1 February 2005

Additional Information

How to Cite

Robbins, K. T. (2005), Is high-dose intensity intraarterial cisplatin chemoradiotherapy for head and neck carcinoma feasible?. Cancer, 103: 447–450. doi: 10.1002/cncr.20807

Author Information

  1. Division of Otolaryngology, Southern Illinois University School of Medicine, Springfield, Illinois

  1. ‡

    Fax: (217) 545-7512

*Division of Otolaryngology, Southern Illinois University School of Medicine, 301 No. Eighth Street, P.O. Box 19662, Springfield, IL 62794-9662

  1. †

    See referenced original article on pages 559–68, this issue.

Publication History

  1. Issue published online: 20 JAN 2005
  2. Article first published online: 4 JAN 2005
  3. Manuscript Accepted: 14 OCT 2004
  4. Manuscript Received: 5 OCT 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (53K)

REFERENCES

  • 1
    Foote RL, Kasperbauer JL, Okuno SH, et al. A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0–N3M0 squamous cell carcinoma of the upper aerodigestive tract. Cancer. 2005; 103: 559–568.
    Direct Link:
  • 2
    Robbins KT, Storniolo AMS, Kerber C, et al. Phase I study of highly supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol. 1994; 12: 2113–2120.
  • 3
    Robbins KT, Kumar P, Regine WF, et al. Efficacy of supradose intra-arterial targeted (SIT) cisplatin (P) and concurrent radiation therapy (RT) in the treatment of unresectable Stage III–IV head and neck carcinoma: the Memphis experience. Int J Radiat Oncol Biol Phys. 1997; 38: 263–271.
  • 4
    Robbins KT, Kumar P, Wong FSH, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000; 22: 687–693.
    Direct Link:
  • 5
    Robbins KT, Kumar P, Harris J, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of Stage IV (T4) head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol. In press.
  • 6
    Balm AJM, Rasch CRN, Schornagel JH, et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck. 2004; 26: 485–493.
    Direct Link:
  • 7
    Wilson WR, Siegel RS, Harisiadis LA, Davis DO, Nguyen HH, Bank WO. High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2001; 127: 809–812.
  • 8
    Regine WF, Valentino J, John W, et al. High-dose intra-arterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: report of a Phase II study. Head Neck. 2000; 22: 543–549.
    Direct Link:
  • 9
    Nibu K, Sugasawa M, Asai M, et al. Results of multimodality therapy for squamous cell carcinoma of maxillary sinus. Cancer. 2002; 94: 1476–1482.
    Direct Link:
  • 10
    Yoshimura R, Shibuya H, Ogura I, et al. Trimodality combination therapy for maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys. 2002; 53: 656–663.
  • 11
    Yokoyama J. [Present role and future prospect of superselective intra-arterial infusion chemotherapy for head and neck cancer]. Gan To Kagaku Ryoho. 2002; 29: 169–175.
  • 12
    Furatani K, Fuwa N, Kodaira T, et al. Continuous selective intra-arterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base. Oral Oncol. 2002; 38: 145–152.
  • 13
    Wang HM, Ng SH, Wang CH, et al. Intra-arterial plus IV chemotherapy for advanced bulky squamous cell carcinoma of the buccal mucosa. Anticancer Drugs. 2001; 12: 331–337.
  • 14
    Kovacs AF, Schiemann M, Turowski B. Combined modality treatment of oral oropharyngeal cancer including neoadjuvant intra-arterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel—three year results of a pilot study. J Craniomaxillofac Surg. 2002; 30: 112–120.
  • 15
    Benazzo M, Caracciolo G, Zappoli F, Bernardo G, Mira E. Induction chemotherapy by superselective intra-arterial high-dose carboplatin infusion for head and neck cancer. Eur Arch Otorhinolaryngol. 2000; 257: 279–282.
  • 16
    Kumar P, Harris J, Garden AS, et al. Outcome comparisons of four radiation therapy oncology group (RTOG) trials in patients with stage IV-T4 head and neck (H/N) cancer: Encouraging results using intra-arterial (IA) cisplatin (P) and concurrent radiation therapy (RT) [Meeting Abstracts]. J Clin Oncol. 2004; 22: 5527.
View Full Article (HTML) Get PDF (53K)